Experimental eye drops aim to target genetic cause of blinding corneal disease
Disease control
Recruiting now
This study is testing an experimental eye drop called DT-168 in patients with Fuchs Endothelial Corneal Dystrophy (FECD), a genetic eye disease that can cause vision loss and often requires a corneal transplant. The main goal is to see if the drops can affect the underlying genet…
Phase: PHASE2 • Sponsor: Design Therapeutics, Inc. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC